Jin Medical International (Jin Medical International) EBITDA Margin % : 12.61% (As of Sep. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Jin Medical International EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Jin Medical International's EBITDA for the six months ended in Sep. 2023 was $1.21 Mil. Jin Medical International's Revenue for the six months ended in Sep. 2023 was $9.57 Mil. Therefore, Jin Medical International's EBITDA margin for the quarter that ended in Sep. 2023 was 12.61%.

Jin Medical International EBITDA Margin % Historical Data

The historical data trend for Jin Medical International's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jin Medical International EBITDA Margin % Chart

Jin Medical International Annual Data

Trend

Sep20

Sep21

Sep22

Sep23

EBITDA Margin %

17.26

14.34

12.99

15.60

Jin Medical International Semi-Annual Data
	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
EBITDA Margin %	Get a 7-Day Free Trial			5.99	12.27	13.69	18.39	12.61

Competitive Comparison of Jin Medical International's EBITDA Margin %

For the Medical Instruments & Supplies subindustry, Jin Medical International's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Jin Medical International's EBITDA Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Jin Medical International's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Jin Medical International's EBITDA Margin % falls into.

Jin Medical International EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Jin Medical International's EBITDA Margin % for the fiscal year that ended in Sep. 2023 is calculated as

EBITDA Margin %	=	EBITDA (A: Sep. 2023 )	/	Revenue (A: Sep. 2023 )
	=	3.093	/	19.821
	=	15.60 %

Jin Medical International's EBITDA Margin % for the quarter that ended in Sep. 2023 is calculated as

EBITDA Margin %	=	EBITDA (Q: Sep. 2023 )	/	Revenue (Q: Sep. 2023 )
	=	1.207	/	9.568
	=	12.61 %

Jin Medical International (NAS:ZJYL) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Jin Medical International EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Jin Medical International's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Jin Medical International (Jin Medical International) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Jin Medical International Ltd (NAS:ZJYL) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 33 Lingxiang Road,, Wujin District, Jiangsu Province, Changzhou City, CHN, KY1-1205

Website

Jin Medical International Ltd offers rehabilitation equipment. It is primarily engaged in the design, development, manufacturing, and sales of wheelchair and other living aids products to be used by people with disabilities or impaired mobility. The Company's products are sold to distributors in both China and in overseas markets. Its product offerings comprise Wheelechaire serirs, Bath products, oxygen machines, nursing products, and conlo products.